Neuro-Oncology
Vestibular schwannoma
May. 27, 2026
Worddefinition
At vero eos et accusamus et iusto odio dignissimos ducimus qui blanditiis praesentium voluptatum deleniti atque corrupti quos dolores et quas.
Hyperventilation syndrome …
- Updated 08.29.2025
- Released 12.06.1996
- Expires For CME 08.29.2028
Hyperventilation syndrome
Introduction
Overview
Hyperventilation syndrome is one of the most common causes of dizziness and paresthesias presented to neurologists, and yet, it is underdiagnosed (76). Interestingly, hyperventilation not infrequently produces predominantly unilateral paresthesias that are more often on the left side, which can be confused with partial seizures, cerebrovascular disease, and multiple sclerosis. Patients may report a variety of psychological complaints, including anxiety, nervousness, unreality, disorientation, or feeling "spacy." Impairment of concentration and memory may be described as part of episodes. Déjà vu or auditory and visual hallucinations can rarely occur.
Key points
|
• Neurologists frequently see patients with hyperventilation syndrome with dizziness and bilateral paresthesia. | |
|
• Ninety-nine percent of cases are chronic hyperventilation syndrome (modest increase in respiratory rate or tidal volume). | |
|
• The paresthesias may be unilateral in 16% of patients, the left side more often than the right. | |
|
• Psychological symptoms may be reported, including nervousness, unreality, disorientation, or feeling “spacey.” | |
|
• Hyperventilation syndrome is commonly misdiagnosed and can often be diagnosed with the hyperventilation provocation test. |
Historical note and terminology
According to a consensus definition, "hyperventilation syndrome is a syndrome characterized by a variety of somatic symptoms induced by physiologically inappropriate hyperventilation and usually reproduced in whole or in part by voluntary hyperventilation" (51). Acute hyperventilation with obvious tachypnea accounts for about 1% of all hyperventilation cases (55). The other 99% of cases are due to chronic hyperventilation, in which there may be a modest increase in respiratory rate or tidal volume, which may not even be apparent to the patient or a medical observer.
The symptoms of hyperventilation syndrome have been recognized for at least 125 years. In 1871, Da Costa published a paper, On Irritable Heart; a Clinical Study of a Form of Functional Cardiac Disorder and Its Consequences, describing 300 Union soldiers in the American Civil War with a mysterious illness (16). He felt the condition could be seen in private practice as well. Symptoms included palpitations, chest pain, shortness of breath or oppression on exertion, indigestion, abdominal distention, and diarrhea. Headache, giddiness, disturbed sleep, and dizziness were "all indicative of disturbed circulation in the cerebrospinal centres." Da Costa reasoned that, "the heart has become irritable, from its over-action and frequent excitement...." During World War I, similar symptoms often associated with fatigue were also attributed to cardiovascular dysfunction and described as "soldier's heart" (52) or "neurocirculatory asthenia" (49). In contrast, Gowers used the terms "vagal" and "vaso-vagal" to describe these symptoms, which could include numbness and tingling of the extremities (31).
In 1922, Goldman was the first to connect "forced ventilation" and tetany and postulated that the tetany was due to alkalosis (29). Kerr and colleagues introduced the term "hyperventilation syndrome," and they described the variety of symptom complexes caused by physical phenomena associated with anxiety states, which could often be reproduced in the examining room with the "hyperventilation test" (44; 45).
Lewis contended that acute and chronic hyperventilation syndrome occurred frequently and described the common and atypical presentations, pathophysiology, and therapy (50). He reported that paresthesias were occasionally asymmetrical and could even be unilateral. Tavel described patients with hyperventilation syndrome presenting with unilateral paresthesias at times associated with subjective unilateral weakness that involved the left side of the face and body more commonly than the right (75).
Clinical manifestations
Presentation and course
The manifestations of hyperventilation syndrome are listed in Table 1. Patients with different symptoms may see different specialists. Cardiologists may see those with complaints of chest pain, palpitations, and shortness of breath. Neurologists frequently see patients describing dizziness and paresthesias (69; 68).
Table 1. Symptoms and Signs of Hyperventilation Syndrome
|
General | |
|
• Fatigability, exhaustion, weakness, sleep disturbance, nausea, sweating | |
|
Cardiovascular | |
|
• Chest pain, palpitations, tachycardia, Raynaud phenomenon | |
|
Gastrointestinal | |
|
• Aerophagia, dry mouth, pressure in the throat, dysphagia, globus hystericus | |
|
Neurologic | |
|
• Headache, pressure in the head, fullness in the head, head warmth | |
|
Psychological | |
|
• Impairment of concentration and memory | |
|
Respiratory | |
|
• Shortness of breath, suffocating feeling, smothering spell, inability to get a good breath or breathe deeply enough, frequent sighing, yawning | |
Hyperventilation syndrome is the most common cause of distal symmetrical paresthesias (58). Although physicians generally recognize bilateral paresthesias of the face, hands, and feet as due to hyperventilation syndrome, many neurologists are not aware that hyperventilation can cause unilateral paresthesias. In two studies of volunteer groups, hyperventilation produced predominantly unilateral paresthesias in 16%, and these involved the left side in over 60% (75; 21; 22). Among those with hand numbness, only the fourth and fifth fingers are often involved. Unusual patterns of numbness reported include one side of the forehead, the shoulders, and one side of the abdomen. Unilateral paresthesias more often involving the left side have also been reported (75; 06; 68; 11; 65).
Patients may report a variety of psychological complaints, commonly including anxiety, nervousness, unreality, disorientation, or feeling "spacy." Impairment of concentration and memory may be described as part of episodes or, alternatively, as symptoms of an underlying anxiety neurosis or depression. A patient's concern about the cause of the various symptoms of hyperventilation may result in feelings of impending death, fear, or panic, which may accentuate the hyperventilation. Those with chronic hyperventilation have severe impairment of health-related quality of life (13). Patients with hyperventilation syndrome have a mean group profile very similar to patients with pseudoseizures: a neurotic pattern where patients respond to psychological stress with somatic symptoms (11). Other complaints, such as déjà vu or auditory and visual hallucinations, are rare (02; 21; 22).
Prognosis and complications
In a follow-up study of children and adolescents, 40% were still hyperventilating as adults, and many suffered from chronic anxiety (36). Half of patients with acute hyperventilation recover without treatment (38). In 10% of those with chronic hyperventilation, symptoms may persist for more than 3 years (38). With proper management, about 70% to 90% of adults become symptom-free (56; 12).
Clinical vignette
A 47-year-old woman presented with a few-week history of daily episodes of lightheadedness, nervousness, and feelings of weakness, coupled with numbness of the left arm, left leg, and perioral area. The numbness was associated with chest tightness and difficulty inhaling and lasted for minutes at a time. She denied any recent stress or depression. She had normal blood and treadmill tests. Past medical history was unremarkable. General physical and neurologic examinations were normal. The hyperventilation test resulted in numbness and tingling periorally and in the left upper and lower extremities. These symptoms were associated with chest tightness.
An MRI scan of the brain with MRA was normal. She was advised to slow her breathing or breathe into a paper bag if additional spells occurred. On follow-up, the episodes had resolved.
Biological basis
Etiology and pathogenesis
Hyperventilation syndrome is frequently associated with anxiety or stress, although some patients have no detectable psychiatric disorder and develop a habit of inappropriately increased ventilatory rate or depth (04).
Common triggers of acute hyperventilation syndrome include anxiety, nausea and vomiting, and fever due to the common cold (38).
In a study of personality traits among 364 patients, only neuroticism was positively associated with self-reported hyperventilation symptoms (18).
Acute hyperventilation reduces arterial pCO2, resulting in alkalosis. Respiratory alkalosis produces the Bohr Effect, a left shift of the oxygen dissociation curve with increased binding of oxygen to hemoglobin and reduced oxygen delivery to the tissues. The alkalosis also causes a reduction in plasma Ca2+ concentration. Hypophosphatemia may be due to intracellular shifts of phosphorus caused by altered glucose metabolism (10). In chronic hyperventilation, bicarbonate and potassium levels may be decreased because of increased renal excretion (67). Finally, stress can produce a hyperadrenergic state that may trigger hyperventilation through beta-adrenergic stimulation (59).
Central and peripheral mechanisms have been postulated to produce neurologic symptoms during hyperventilation (05). Voluntary hyperventilation can reduce cerebral blood flow by 30% to 40% (30; 42). Symptoms and signs such as headache, visual disturbance, dizziness, tinnitus, ataxia, syncope, and various psychological symptoms may be produced by diminished cerebral perfusion.
The precise cause of generalized slowing of brain waves during hyperventilation is uncertain. This response is most common and pronounced in children and teenagers, diminishes in young adults, and is rare in the elderly. A brainstem-mediated response to hypocarbia has been proposed (66). The response may be due to metabolic rather than just hemodynamic factors (46). Hypoglycemia can accentuate the generalized slowing or buildup.
There have been additional postulates to explain the manifestations of hyperventilation. Muscle spasms and tetany may be due to respiratory alkalosis and hypocalcemia. The finding that there is no relationship between the rate of fall of pCO2 and the onset of dizziness and paresthesias suggests that symptoms may be due to hypophosphatemia (70). Hypophosphatemia can result in symptoms such as tiredness, dizziness, poor concentration, disorientation, and paresthesia. A hyperadrenergic state may result in tremors, tachycardia, anxiety, and sweating. Hypokalemia can cause muscle weakness and lethargy.
The cause of bilateral and unilateral paresthesias is not certain; evidence exists for both a central and a peripheral mechanism. A reduction in the concentration of extracellular Ca2+ may increase peripheral nerve axonal excitability, resulting in spontaneous bursting activity of cutaneous axons, perceived as paresthesias (58). Lateralization of symptoms might be explained by anatomic differences in the peripheral nerves and their nutrient vessels (24).
Alternatively, symmetrically decreased cerebral perfusion could account for bilateral paresthesias and asymmetrically decreased perfusion for unilateral paresthesias. O'Sullivan and colleagues reported nonspecific, asymmetric slowing of brain waves in the hemisphere opposite to the side of unilateral paresthesias in hyperventilators and normal bilateral somatosensory evoked potentials (65). Although anatomic differences in the cerebral vasculature might explain the unilateral paresthesias, normal magnetic resonance angiographic findings in two cases argue against this (21). Additionally, there is a single report of asymmetrically decreased cerebral blood flow with decreased flow in the right parietal area with left-sided symptoms (21).
It is not known why unilateral paresthesias occur more often on the left side of the face and body. One hypothesis is that psychosomatic symptoms are associated with right hemisphere psychic processes. During stress and emotional arousal, the right hemisphere is activated more than the left (80). Symptoms of conversion or hyperventilation are more likely to occur on the left side of the face and body (24; 65). However, this hypothesis does not explain the increased frequency of left-sided paresthesias in normal subjects who are asked to hyperventilate.
Epidemiology
Hyperventilation syndrome occurs in about 6% to 11% of the general patient population (08). In a clinic that evaluated patients with dizziness, hyperventilation syndrome accounted for 24% of the cases (19). Most studies have reported hyperventilation syndrome occurring two to seven times more frequently in women than in men, with most patients ranging in age between 15 and 55 years (26). One large study reported that patients with acute hyperventilation syndrome ranged in age from 5 to 85 years, and it was particularly prevalent in women in their late teens (38). Hyperventilation syndrome may have a high incidence after COVID-19 infection (78), affecting 15.6% of COVID-19 pneumonia survivors at 1 month (14).
Using a questionnaire, a French study found a prevalence of chronic hyperventilation syndrome in 24.7% of girls and 16.2% of boys among children ages 1 to 17 years (32). The prevalence of chronic hyperventilation is highest in middle-aged women (38). In studies of patients with neurologic symptoms of hyperventilation syndrome, the percentage of females ranges from 50% (06) to 67% (68; 11; 65) to 87% (69).
Prevention
For psychogenic cases of hyperventilation syndrome, avoidance of triggers is a preventative measure.
Differential diagnosis
Hyperventilation syndrome has organic and physiological as well as emotional and habitual causes. Less than 5% of hyperventilation has a solely organic cause, 60% has a psychogenic (emotional and habitual) basis, and the remainder has varying combinations (09). The variety of organic disorders that can result in hyperventilation include: (1) effects of salicylate, caffeine, topiramate (48), and other drugs; (2) cirrhosis and hepatic coma; (3) acute pain such as that accompanying a myocardial infarction; (4) splenic flexure syndrome, cholecystitis, fever, and sepsis; and (5) dissecting aortic aneurysm, respiratory dyskinesia, pulmonary embolism, pneumothorax, interstitial lung disease, asthma, and heat and altitude acclimatization (08; 07).
There is an association between hyperventilation syndrome diagnosis and a history of patients who were not hospitalized with COVID-19 (01). Hyperventilation syndrome was common in a prospective study of long COVID-19 patients with dysfunctional breathing without underlying disease to explain the symptoms (27).
Neurologic disorders that may cause hyperventilation include Rett syndrome, Joubert syndrome, Reye syndrome, pyruvate dehydrogenase deficiency, biotin-dependent multiple carboxylase deficiency, malignant hyperthermia, brainstem tumor, primary cerebral lymphoma, encephalitis, brainstem strokes, thalamic hemorrhage, syringobulbia, and neurogenic pulmonary edema due to intracranial hypertension (05). Severe hyperventilation can occur in the absence of psychiatric, respiratory, neurologic, or other organic abnormalities (04).
In patients diagnosed with hyperventilation syndrome by neurologists, the misdiagnoses of referring physicians have included epilepsy, migraine, multiple sclerosis, arteriovenous malformation, cerebrovascular disease, vertebrobasilar insufficiency, brachial neuritis, angina, malingering, vasovagal attacks, functional illness, hypoglycemia, and cerebral tumor (06; 68). Hyperventilation might also contribute to some of the manifestations of migraine, such as syncope.
Cardiac abnormalities should certainly be considered in those patients with chest pain. The distinction between angina and hyperventilation syndrome at times is difficult because hyperventilation can produce electrocardiogram changes, including T-wave inversions, systolic time-segment depression, and systolic time-segment elevation in patients without coronary artery disease (35; 17). Some patients with angina may hyperventilate in response to their pain and anxiety. The symptoms of mitral valve prolapse and hyperventilation syndrome overlap. Some patients may have symptoms due to hyperventilation (77).
The symptoms of panic attacks greatly overlap with hyperventilation syndrome, and the differential diagnosis is quite similar (79; 73). The pathophysiology of panic attacks is controversial; hyperventilation syndrome has been suggested as a cause (53; 64; 23) and as an inducer of panic attacks (62). Patients diagnosed with panic attacks that report brief episodic unilateral paresthesias or weakness may have the neurologic symptoms reproduced with the hyperventilation test (15).
Tonic spasms (paroxysmal dystonia) of multiple sclerosis can be somewhat similar to the muscle spasms, tetany, and paresthesias of hyperventilation syndrome. The episodes consist of brief, recurrent, often painful, abnormal posturing of one or more extremities without alteration of consciousness, loss of sphincter control, or clonic movements. They last for 10 seconds to 3 minutes and recur as often as 30 times daily. Some patients may experience brief sensory disturbances in the involved extremity before or during the attack. Because the episodes can be the initial presentation of multiple sclerosis (34) and can be triggered by hyperventilation (72), diagnostic confusion might result.
Diagnostic workup
The acute form of hyperventilation syndrome is easily recognized. However, the chronic form is less easily recognized because the breathing rate is not reported as rapid or does not appear rapid and because the symptoms may appear atypical. For example, a respiration rate of 18 per minute combined with an increased tidal volume of 750 mL per minute may lead to overbreathing that is not easily detectable. Because the chronic disorder is intermittent, spot arterial pCO2 or end-tidal volume pCO2 results can be normal. The diagnosis depends on reproducing some or all of the symptoms with the hyperventilation provocation test and excluding other possible causes by either clinical reasoning or laboratory testing when indicated. Patients frequently report only one or two symptoms but on performing the hyperventilation provocation test, report other symptoms that appear during their typical episodes that they had forgotten.
The hyperventilation provocation test can be performed with either an increased ventilation rate of up to 60 per minute or simply deep breathing for 3 minutes (57). Based on a study of healthy subjects, a minimum duration of 3 minutes and end-tidal pCO2 decreasing to at least 1.9 kPa or dropping well over 50% of baseline should elicit symptoms in most people (39). Dizziness, unsteadiness, and blurred vision commonly develop within 20 to 30 seconds, especially with the patient in the standing position; paresthesias start later (57). Chest pain is reported by 50% of patients after 3 minutes of hyperventilation and by all by 20 minutes (20). For clinical purposes, measurement of end tidal volume pCO2 is not necessary. In addition, there is no clear correlation between paCO2 and neurologic signs (74). The hyperventilation provocation test should not be performed in patients with ischemic heart disease, cerebrovascular disease, pulmonary insufficiency, hyperviscosity states, significant anemia, sickle cell disease, or uncontrolled hypertension (08).
For some patients with hyperventilation syndrome, symptoms cannot be reliably reproduced during the hyperventilation provocation test or even on consecutive tests (38). In some cases, the hyperventilation provocation test lacks test-retest reliability (54). For others, antecedent anxiety and stress, not present during the test, may predispose to symptom formation, perhaps because of a hyperadrenergic state (59; 68). Different patterns of hyperventilation with different respiratory rates, tidal volumes, and durations may induce different symptoms (33; 39). Finally, as a response to a change in body position from supine to standing, patients with hyperventilation syndrome have an accentuated increase in ventilation that can be calculated with noninvasive measurements of pulmonary gas exchange, and that distinguishes them from healthy subjects (60).
Interestingly, in a study of 50 patients with electrophysiologically proven carpal tunnel syndrome who presented to outpatient surgery for decompression, 86% had their symptoms of carpal tunnel reproduced by hyperventilation with no false positives (03).
A double-blind, placebo-controlled study found the hyperventilation provocation test invalid (40). Because hyperventilation seemed a negligible factor in the experience of spontaneous symptoms, Hornsveld and colleagues even recommended avoiding the term "hyperventilation syndrome." However, the study may be flawed because of the method of patient selection. Patients were referred because of a suspicion of hyperventilation syndrome and not based on reproduction of symptoms on a hyperventilation provocation test. Moreover, the presenting symptoms of subjects were not provided. Because the symptoms of hyperventilation syndrome can indeed be vague and nonspecific and because symptoms sometimes occur only with certain types of anxiety or stress, their conclusion may not apply to different population subsets (63). The subjects' symptoms may have been due to chest wall pain or panic attacks.
Alternatively, the Nijmegen questionnaire (a list of 16 symptoms rated on a 5-point scale from never to very often) can screen for hyperventilation syndrome. The efficacy of this questionnaire has been evaluated, revealing the sensitivity to be 91% and the specificity to be 95% (when using the clinical diagnosis based on the pattern of complaints as the gold standard) (81). In a consecutive series of 100 patients in a neuro-otology practice, 23% of patients seen for vestibular assessment were diagnosed with hyperventilation syndrome; 74% of these would have potentially remained undetected had the Nijmegen questionnaire not been used (41).
From my experience with patients with predominantly neurologic complaints, the concept of hyperventilation syndrome is valuable, and the hyperventilation provocation test, despite its recognized shortcomings (25), is useful. In the individual case, if the hyperventilation provocation test fails to reproduce the symptoms but clinical suspicion persists, treatment such as breath holding, slow breathing, or breathing into a paper bag can certainly be suggested on a trial basis.
Management
The various treatments for hyperventilation that have been proposed include patient reassurance and education, instructions to hold the breath, breathe more slowly, or breathe into a paper bag, along with breathing exercises and diaphragmatic retraining, biofeedback, hypnosis, psychological and psychiatric treatment, and medications such as beta-blockers, benzodiazepines, and antidepressants (05). A study of nonpharmacologic treatments found efficacy for educational sessions, breathing techniques and retraining, and progressive relaxation; the greatest improvement occurred in the group given an explanation and eight sessions of breathing retraining (61). A small study found benefit from “grounding therapy,” a physical exercise inspired by African dance (71). A small pilot study found benefit from acupuncture (28). There is a lack of well-controlled treatment trials comparing these approaches, including breathing exercises (37; 43).
In my experience, most patients respond to reassurance, education, and instructions to hold their breath, breathe more slowly, or breathe into a paper bag. Providing the patient with written materials such as those used by Lance may be worthwhile (47). If significant symptoms of stress, anxiety, or depression are present, use of appropriate medication and psychological or psychiatric referral may be helpful.
Special considerations
Pregnancy
Although hyperventilation syndrome has often been seen during pregnancy, studies on the incidence are not available.
References
- 01
- Allado E, Poussel M, Hamroun A, et al. Is there a relationship between hyperventilation syndrome and history of acute SARS-CoV-2 infection? A cross-sectional study. Healthcare (Basel) 2022;10(11):2154. PMID 36360494
- 02
- Allen TE, Agus B. Hyperventilation leading to hallucinations. Am J Psychiatry 1968;125:632-7. PMID 5683449
- 03
- Aslam U, Afzal S, Syed S. Hyperventilation provokes symptoms of carpal tunnel syndrome. Hand Surg 2012;17:337-9. PMID 23061942
- 04
- Bass C, Gardner WN. Respiratory and psychiatric abnormalities in chronic symptomatic hyperventilation. BMJ 1985;290:1387-90. PMID 3922504
- 05
- Beumer HM, Bruyn GW. Hyperventilation syndrome. In: Goetz CG, Tanner CM, Aminoff MJ, editors. Handbook of clinical neurology. Vol. 19. Amsterdam: Elsevier, 1993:429-48.
- 06
- Blau JN, Wiles CM, Solomon FS. Unilateral somatic symptoms due to hyperventilation. BMJ 1983;286:1108. PMID 6404345
- 07
- Block M, Szidon P. Hyperventilation syndromes. Comp Ther 1994;20:306-11. PMID 8045089
- 08
- Brashear RE. Hyperventilation syndrome. Lung 1983;161:257-73. PMID 6138480
- 09
- Brashear RE. Hyperventilation syndrome: managing elderly patients. Geriatrics 1984;39:114-25. PMID 6145660
- 10
- Brautbar N, Leibovici H, Finlander P, et al. Mechanism of hypophosphatemia during acute hyperventilation. Clin Res 1980;28:387A.
- 11
- Brodtkorb E, Gimse R, Antonaci F, et al. Hyperventilation syndrome: clinical, ventilatory, and personality characteristics as observed in neurological practice. Acta Neurol Scand 1990;81:307-13. PMID 2360397
- 12
- Campernolle T, Hoogduin K, Joele L. Diagnosis and treatment of the hyperventilation syndrome. Psychosomatics 1979;20:612-25. PMID 493485
- 13
- Chenivesse C, Similowski T, Bautin N, et al. Severely impaired health-related quality of life in chronic hyperventilation patients: exploratory data. Respir Med 2014;108(3):517-23. PMID 24269004
- 14
- Cherif H, Mokaddem S, Debiche S, Kalboussi S, Yangui F, Charfi MR. Incidence and predictive factors of hyperventilation syndrome in patients after COVID-19 pneumonia: a prospective cohort study. F1000Res 2024;13:1497. PMID 40242142
- 15
- Coyle PK, Sterman AB. Focal neurologic symptoms in panic attacks. Am J Psychiatry 1986;143:648-9. PMID 3963257
- 16
- Da Costa JM. On irritable heart; a clinical study of a form of functional cardiac disorder and its consequences. Am J Med Sci 1871;71:2-52.
- 17
- Dash S, Kumar A. Hyperventilation leading to transient T-wave inversion mimicking unstable angina. Cureus 2021;13(1):e12980. PMID 33659120
- 18
- Decuyper M, De Bolle M, Boone E, De Fruyt F. The relevance of personality assessment in patients with hyperventilation symptoms. Health Psychol 2012;31(3):316-22 PMID 22149121
- 19
- Drachman DA, Hart CW. An approach to the dizzy patient. Neurology 1972;22:323-34. PMID 4401538
- 20
- Evans DW, Lum LC. Hyperventilation: an important cause of pseudoangina. Lancet 1977;22(1):155-7. PMID 64694
- 21
- Evans RW. Neurologic aspects of hyperventilation syndrome. Semin Neurol 1995;15:115-25. PMID 7481131
- 22
- Evans RW. Hyperventilation syndrome. In Kaplan PW, Fisher RS, editors. Imitators of epilepsy. New York: Demos, 2005:241-53.
- 23
- Folgering H. The pathophysiology of hyperventilation syndrome. Monaldi Arch Chest Dis 1999;54(4):365-72. PMID 10546483
- 24
- Galin D, Dimond R, Braff D. Lateralization of conversion symptoms more frequent on the left. Am J Psychiatry 1977;134:578-80. PMID 848593
- 25
- Gardner W. Orthostatic increase of respiratory gas exchange in hyperventilation syndrome. Thorax 2000;55:257-9. PMID 10722762
- 26
- Garssen B, Rijken H. Hyperventilation syndrome. In: Kaptein AA, van der Ploeg HM, Schreurs PJG, Beunderman R, editors. Behavioural medicine. John Wiley and Sons, 1990:159-72.
- 27
- Genecand L, Altarelli M, Binkova A, et al. Dysfunctional breathing symptoms, functional impact and quality of life in patients with long COVID-19: a prospective case series. BMJ Open Respir Res 2023;10(1):e001770. PMID 37433720
- 28
- Gibson D, Bruton A, Lewith GT, Mullee M. Effects of acupuncture as a treatment for hyperventilation syndrome: a pilot, randomized crossover trial. J Altern Complement Med 2007;13(1):39-46. PMID 17309376
- 29
- Goldman A. Clinical tetany by forced respiration. JAMA 1922;78:1193-5.
- 30
- Gotoh F, Meyer JS, Takagi Y. Cerebral effects of hyperventilation in man. Arch Neurol 1965;12:410-23. PMID 14264873
- 31
- Gowers WR. The border-land of epilepsy. Faints, vagal attacks, vertigo, migraine, sleep symptoms, and their treatment. London: J and A Churchill, 1907.
- 32
- Gridina I, Bidat E, Chevallier B, Stheneur C. [Prevalence of chronic hyperventilation syndrome in children and teenagers]. Arch Pediatr 2013;20(3):265-8. PMID 23375424
- 33
- Grossman P, de Swart JC. Diagnosis of hyperventilation syndrome on the basis of reported complaints. J Psychosom Res 1984;28:97-104. PMID 6429325
- 34
- Heath PD, Nightingale S. Clusters of tonic spasms as an initial manifestation of multiple sclerosis. Ann Neurol 1982;12:494-5. PMID 7181456
- 35
- Heckerling PS, Hanashiro PK. ST segment elevation in hyperventilation syndrome. Ann Emerg Med 1985;14:126-7. PMID 4051283
- 36
- Herman SP, Stickler GB, Lucas AR. Hyperventilation syndrome in children and adolescents: long-term follow up. Pediatrics 1981;67:183-7. PMID 7243442
- 37
- Herxheimer A. How much drug in the tablet. [letter; comment]. Lancet 1991;337(8748):1042. Herxheimer A. How much drug in the tablet? Lancet 1991;337(8748):1042 PMID 1671244
- 38
- Hirokawa Y, Kondo T, Ohta Y, Kanazawa O. Clinical characteristics and outcome of 508 patients with hyperventilation syndrome. Nippon Kyobu Shikkan Gakkai Zasshi 1995;33:940-6. PMID 8538089
- 39
- Hornsveld H, Garssen B, van Spiegel P. Voluntary hyperventilation: the influence of duration and depth on the development of symptoms. Biol Psychol 1995;40:299-312. PMID 7669838
- 40
- Hornsveld HK, Garssen B, Dop MJ, van Spiegel PI, de Haes JC. Double-blind placebo-controlled study of the hyperventilation provocation test and the validity of the hyperventilation syndrome. Lancet 1996;348:154-8. PMID 8684155
- 41
- Humphriss RL, Baguley DM, Andersson G, Wagstaff S. Hyperventilation in the vestibular clinic: use of the Nijmegen Questionnaire. Clin Otolaryngol 2004;29:232-7. PMID 15142067
- 42
- Jibiki I, Kurokawa K, Matsuda H, Fukushima T, Yamaguchi N, Hisada K. Widespread reduction of regional cerebral blood flow during hyperventilation-induced EEG slowing ('buildup'). Observation from subtraction of brain imaging with single photon emission computed tomography using technetium-99m hexamethyl-propyleneamine oxime. Neuropsychobiology 1992;26(3):120-4. PMID 1294891
- 43
- Jones M, Harvey A, Marston L, O'Connell NE. Breathing exercises for dysfunctional breathing/hyperventilation syndrome in adults. Cochrane Database Syst Rev 2013;5:CD009041. PMID 23728685
- 44
- Kerr WJ, Dalton JW, Gliebe PA. Some physical phenomena associated with the anxiety states and their relation to hyperventilation. Ann Int Med 1937;11:961-91.
- 45
- Kerr WJ, Gliebe PA, Dalton JW. Physical phenomena associated with anxiety states: the hyperventilation syndrome. Calif West Med 1938;48(1):12-6. PMID 18744341
- 46
- Kraaier V, Van Huffelen AC, Wieneke GH, Van der Worp HB, Bar PR. Quantitative EEG changes due to cerebral vasoconstriction. Indomethacin versus hyperventilation-induced reduction in cerebral blood flow in normal subjects. Electroencephalogr Clin Neurophysiol 1992;82(3):208-12. PMID 1371441
- 47
- Lance JW, Goadsby PJ. Appendix A. An explanation of hyperventilation. In: Mechanism and management of headache. 7th ed. Oxford: Butterworth Heinemann, 2005.
- 48
- Laskey AL, Korn DE, Moorjani BI, Patel NC, Tobias JD. Central hyperventilation related to administration of topiramate. Pediatr Neurol 2000;22:305-8. PMID 10788749
- 49
- Levine SA. The origin of the term neurocirculatory asthenia. N Engl J Med 1965;273:604-5. PMID 14329634
- 50
- Lewis BI. The hyperventilation syndrome. Ann Int Med 1953;38:918-27. PMID 13041034
- 51
- Lewis RA, Howell JB. Definition of the hyperventilation syndrome. Bull Eur Physiopathol Respir 1986;22:201-4. PMID 3708188
- 52
- Lewis T. The soldier's heart and the effort syndrome. New York: Paul B Hoeber, 1919.
- 53
- Ley R. Agoraphobia, the panic attack and the hyperventilation syndrome. Behav Res Ther 1985;1:79-81. PMID 3985919
- 54
- Lindsay S, Saqi S, Bass C. The test-retest reliability of the hyperventilation provocation test. J Psychosom Res 1991;35:155-62. PMID 1904496
- 55
- Lum LC. Hyperventilation: the tip and the iceberg. J Psychosom Res 1975;19:375-83. PMID 1214233
- 56
- Lum LC. The syndrome of chronic habitual hyperventilation. In: Hill OW, editor. Modern trends in psychosomatic medicine. London: Buttersworth, 1976:196-230.
- 57
- Lum LC. Hyperventilation syndromes in medicine and psychiatry: a review. J R Soc Med 1987;80:229-31. PMID 3295237
- 58
- Macefield G, Burke D. Paraesthesiae and tetany induced by voluntary hyperventilation. Increased excitability of human cutaneous and motor axons. Brain 1991;114:527-40. PMID 2004255
- 59
- Magarian GJ. Hyperventilation syndromes: infrequently recognized common expressions of anxiety and stress. Medicine 1982;61:219-36. PMID 7045570
- 60
- Malmberg LP, Tamminen K, Sovijarvi AR. Orthostatic increase of respiratory gas exchange in hyperventilation syndrome. Thorax 2000;55:295-301. PMID 10722769
- 61
- Monday J, Gautrin D, Cartier A. Chronic hyperventilation syndrome. The role of respiratory re-training. Rev Mal Respir 1995;12:291-8. PMID 7638426
- 62
- Nardi AE, Freire RC, Zin WA. Panic disorder and control of breathing. Respir Physiol Neurobiol 2009;167(1):133-43. PMID 18707030
- 63
- Naschitz JE, Yeshurun D, Hardoff D, Yaffe M. Hyperventilation syndrome. Lancet 1996;348:750. PMID 8806301
- 64
- Nutt D, Lawson C. Panic attacks. A neurochemical overview of models and mechanisms. Br J Psychiatry 1992;160:165-78. PMID 1540756
- 65
- O'Sullivan G, Harvey I, Bass C, Sheehy M, Toone B, Turner S. Psychophysiological investigations of patients with unilateral symptoms in the hyperventilation syndrome. Br J Psychiatry 1992;160:664-7. PMID 1317239
- 66
- Patel VM, Maulsby RI. How hyperventilation alters the electroencephalogram: a review of controversial viewpoints emphasizing neurophysiological mechanisms. J Clin Neurophysiol 1987;4:101-20. PMID 3305571
- 67
- Pearson MG, Qadiri MR, Finn R. Hypokalaemia in the chronic hyperventilation syndrome. Br J Clin Pract 1986;40:28-9. PMID 3707822
- 68
- Perkin GD, Joseph R. Neurological manifestations of the hyperventilation syndrome. J R Soc Med 1986;79:448-50. PMID 3761286
- 69
- Pincus JH. Disorders of conscious awareness. Hyperventilation syndrome. Br J Hosp Med 1978;19:312-3. PMID 656666
- 70
- Rafferty GF, Saisch SGN, Gardner WN. Relation of hypocapnic symptoms to rate of fall of end-tidal PCO2 in normal subjects. Respir Med 1992;86:335-40. PMID 1448588
- 71
- Ristiniemi H, Perski A, Lyskov E, Emtner M. Hyperventilation and exhaustion syndrome. Scand J Caring Sci 2014;28(4):657-64. PMID 24134551
- 72
- Shibasaki H, Kuroiwa Y. Painful tonic seizure in multiple sclerosis. Arch Neurol 1974;30:47-51. PMID 4586026
- 73
- Stahl SM, Soefje S. Panic attacks and panic disorder: the great neurologic impostors. Semin Neurol 1995;15:126-32. PMID 7481132
- 74
- Stoop A, de Boo T, Lemmens W, Folgering H. Hyperventilation syndrome: measurement of objective symptoms and subjective complaints. Respiration 1986;49:37-44. PMID 3081975
- 75
- Tavel ME. Hyperventilation syndrome with unilateral somatic symptoms. JAMA 1964;187:301-2. PMID 14074470
- 76
- Tavel ME. Hyperventilation syndrome: why is it regularly overlooked? Am J Med 2021;134:13-15. PMID 32791056
- 77
- Tavel ME. Hyperventilation syndrome-hiding behind pseudonyms. Chest 1990;97:1285-8. PMID 2189694
- 78
- Taverne J, Salvator H, Leboulch C, et al. High incidence of hyperventilation syndrome after COVID-19. J Thorac Dis 2021;13(6):3918-22. PMID 34277081
- 79
- Tesar GE, Rosenbaum JF. Recognition and management of panic disorder. Adv Intern Med 1993;38:123-49. PMID 8438634
- 80
- Tucker DM, Roth RS, Arneson BA, Buckingham V. Right hemisphere activation during stress. Neuropsychologia 1977;15:697-700. PMID 896027
- 81
- van Dixhoorn J, Duivenvoorden HJ. Efficacy of Nijmegen Questionnaire in recognition of the hyperventilation syndrome. J Psychosom Res 1985;29:199-206. PMID 4009520
Contributors
All contributors' financial relationships have been reviewed and mitigated to ensure that this and every other article is free from commercial bias.
Author
-
Randolph W Evans MD
Dr. Evans of Baylor College of Medicine received speaker honorariums from Abbvie.
See Profile
Patient Profile
- Age range of presentation
-
- 6 to 65+ years
- Sex preponderance
-
- female>male, >2:1
- Heredity
-
- none
- Population groups selectively affected
-
- none selectively affected
- Occupation groups selectively affected
-
- none selectively affected
ICD & OMIM codes
- ICD-10
-
- Hyperventilation: R06.4
- ICD-11
-
- Hyperventilation: MD11.7
This is an article preview.
Start a Free Account
to access the full version.
-
Nearly 3,000 illustrations, including video clips of neurologic disorders.
-
Every article is reviewed by our esteemed Editorial Board for accuracy and currency.
-
Full spectrum of neurology in 1,200 comprehensive articles.
-
Listen to MedLink on the go with Audio versions of each article.
Questions or Comment?
MedLink, LLC
3525 Del Mar Heights Rd, Ste 304
San Diego, CA 92130-2122
Toll Free (U.S. + Canada): 800-452-2400
US Number: +1-619-640-4660
Support: service@medlink.com
Editor: editor@medlink.com
ISSN: 2831-9125
Also in This Category
-
-
Neuropharmacology & Neurotherapeutics
Upadacitinib
May. 14, 2026
-
General Child Neurology
Ataxia-telangiectasia
May. 12, 2026
-
Infectious Disorders
Cryptococcal meningitis
May. 01, 2026
-
Neurogenetic Disorders
GM2 gangliosidoses
Apr. 30, 2026
-
General Child Neurology
Developmental delay in children: evaluation and management
Apr. 29, 2026
-
Neuropharmacology & Neurotherapeutics
Levacetylleucine
Apr. 23, 2026
-
Neuropharmacology & Neurotherapeutics
Dextromethorphan hydrobromide and quinidine sulfate
Apr. 23, 2026